A 74-year-old woman with acute calculous cholangitis underwent ERCP and a pancreatic stent (PS) was placed to prevent post-ERCP pancreatitis after difficult cannulation.
During the procedure, an endoscopic papillary balloon dilation caused the stent to migrate into the main pancreatic duct (MPD).
The migrated stent was successfully removed in a follow-up ERCP two days later, highlighting the potential risks of stent migration with early placement during ERCP procedures.
The study assessed the safety and effectiveness of using aggressive hydration and rectal non-steroidal anti-inflammatory drugs to prevent pancreatitis after an ERCP procedure.
Conducted at 12 medical centers with 231 patients, the trial found that only 5.6% developed post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) after treatment.
Results indicate that this combined approach is a safe and effective preventive strategy, including for elderly patients.